Regencell Bioscience Holdings Limited (RGC) vs Trulieve Cannabis Corp. (TRLV)

Regencell Bioscience Holdings Limited and Trulieve Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $2.6B against $2.1B — 1.2× the size. Regencell Bioscience Holdings Limited has the higher net margin (0.00% vs −41.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Regencell Bioscience Holdings Limited leads on 5 and Trulieve Cannabis Corp. on 4.

Valuation

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S — 1.98 2.08
P/B n/m 2.77 1.79
Price to free cash flow n/m 11.84 16.29
EV/EBITDA 1.13 n/m 12.22
EV/Sales n/m 1.99 2.87
Earnings yield (19.96%) (22.28%) (15.94%)
Free cash flow yield 0.00% 8.44% 0.00%

Profitability

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
Gross margin — 60.64% 53.51%
Operating margin — 0.00% 0.00%
Net margin 0.00% (41.22%) (2.45%)
Free cash flow margin 0.00% 22.43% 0.00%
Return on equity 0.00% (45.52%) (0.80%)
Return on assets 0.00% (17.61%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (9.09%) 5.22%
EPS growth (last fiscal year) (177.78%) 26.58% 42.91%
Revenue growth, 5-year CAGR — 17.76% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 10.77 5.52 2.41
Net debt to EBITDA 1.22 0.11 1.01

Dividend

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric RGC TRLV Drug Manufacturers Specialty & Generic median
Market cap 2.61b 2.10b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack